A detailed history of Merit Financial Group, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 10,085 shares of NKTX stock, worth $20,976. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,085
Previous 10,668 5.46%
Holding current value
$20,976
Previous $17,000 17.65%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

SELL
$1.67 - $2.37 $973 - $1,381
-583 Reduced 5.46%
10,085 $20,000
Q2 2025

Jul 22, 2025

BUY
$1.51 - $2.22 $16,108 - $23,682
10,668 New
10,668 $17,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $101M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Merit Financial Group, LLC Portfolio

Follow Merit Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Merit Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merit Financial Group, LLC with notifications on news.